Amelia Fuller

Dr. Amelia Fuller

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2013 in Organic Letters
Verified
Journal Article
Closed access
AFAmelia Fuller
Amelia Fuller
BYBrett A. Yurash
Brett A. Yurash
ESErik N. Schaumann
Erik N. Schaumann
FSFrederick J. Seidl
Frederick J. Seidl

1 January 2011 in Peptide Science
Verified
Journal Article
Closed access
PDF file
AFAmelia Fuller
Amelia Fuller
FSFrederick J. Seidl
Frederick J. Seidl
PBPaul A. Bruno
Paul A. Bruno
MPMarisa A. Plescia
Marisa A. Plescia
KPKanwal S. Palla
Kanwal S. Palla

22 March 2013 in Peptide Science
Verified
Journal Article
Closed access
PDF file
AFAmelia Fuller
Amelia Fuller
CHCourtney A. Holmes
Courtney A. Holmes
FSFrederick J. Seidl
Frederick J. Seidl

14 October 2021 in ACS Chemical Biology
Verified
Journal Article
Open access
SWSean R. Wallace
Sean R. Wallace
LCLeila Y. Chihab
Leila Y. Chihab
MYMiles Yamasaki
Miles Yamasaki
BYBraden T. Yoshinaga
Braden T. Yoshinaga
YTYazmin M. Torres
Yazmin M. Torres
ICIan Carter-O'Connell
Ian Carter-O'Connell
Poly(ADP-ribose) polymerases, PARPs, transfer ADP-ribose onto target proteins from nicotinamide adenine dinucleotide (NAD+). Current mass spectrometric analytical methods require proteolysis of target proteins, limiting the study of dynamic ADP-ribosylation on contiguous proteins. Herein, we present a matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) method that facilitates multisite analysis of ADP-ribosylation. We observe divergent ADP-ribosylation dynamics for the catalytic domains of PARPs 14 and 15, with PARP15 modifying more sites on itself (+3–4 ADP-ribose) than the closely related PARP14 protein (+1–2 ADP-ribose)—despite similar numbers of potential modification sites. We identify, for the first time, a minimal peptide fragment (18 amino-acids) that is preferentially modified by PARP14. Finally, we demonstrate through mutagenesis and chemical treatment with hydroxylamine that PARPs 14/15 prefer acidic residues. Our results highlight the utility of MALDI-TOF in the analysis of PARP target modifications and in elucidating the biochemical mechanism governing PARP target selection.


26 November 2020 in ACS Chemical Biology
Verified
Journal Article
Open access
AFAmelia Fuller
Amelia Fuller
ADAmy Dounay
Amy Dounay
DSDouglas Schirch
Douglas Schirch
DRDaniel G. Rivera
Daniel G. Rivera
Karl HansfordKarl Hansford
Karl Hansford
WSWilliam L. Scott
William L. Scott
New antibiotics are urgently needed to address increasing rates of multidrug resistant infections. Seventy-six diversely functionalized compounds, comprising five structural scaffolds, were synthesized and tested for their ability to inhibit microbial growth. Twenty-six compounds showed activity in the primary phenotypic screen at the Community for Open Antimicrobial Drug Discovery (CO-ADD). Follow-up testing of active molecules confirmed that two unnatural dipeptides inhibit the growth of Cryptococcus neoformans with a minimum inhibitory concentration (MIC) ≤ 8 μg/mL. Syntheses were carried out by undergraduate students at five schools implementing Distributed Drug Discovery (D3) programs. This report showcases that a collaborative research and educational process is a powerful approach to discover new molecules inhibiting microbial growth. Educational gains for students engaged in this project are highlighted in parallel to the research advances. Aspects of D3 that contribute to its success, including an emphasis on reproducibility of procedures, are discussed to underscore the power of this approach to solve important research problems and to inform other coupled chemical biology research and teaching endeavors.